Ayoxxa Biosystems
Biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Ayoxxa Biosystems?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Ayoxxa Biosystems (stylized in its logo as AYOXXA) is a biotechnology company founded in 2010 in Singapore, and headquartered in Germany.[1][2]
Quick Facts Company type, Industry ...
![]() | |
Company type | Private |
---|---|
Industry | Biotech |
Founded | Singapore (2010), Germany (2012) |
Founder | Andreas Schmidt, Dieter Trau |
Headquarters | , Germany |
Key people | Albrecht Läufer (CEO), Markus Zumbansen (CTO) |
Products | Development of a Protein chip platform based on the Bead-based Arrays, named LUNARIS (TM) multiplexing technology |
Production output | Biomarker Detection Kits |
Services | Multiplexing and Readout Services, Assay Development Services |
Owner | Prosnav Capital, and others |
Subsidiaries | Ayoxxa Inc. (USA), Ayoxxa Living Health Technologies Pte. Ltd (Singapore) |
Website | www |
Close
The company is known for developing protein chip capable of detecting at once multiple biomarkers, biomarker signatures (including markers for cancer, allergies, age related macular degeneration AMD, or infectious diseases) from a small biological sample. The protein chip yields large amounts of data, being primarily aimed for use in biomedical research in academia, clinic and industry.[1][3][4][5][6]